381
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Memory CD8 + T Cells Are Required for Protection from Persistent Hepatitis C Virus Infection

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Few hepatitis C virus (HCV) infections resolve spontaneously but those that do appear to afford protective immunity. Second infections are usually shorter in duration and are less likely to persist but mechanisms of virus control in immune individuals have not been identified. In this study we investigated whether memory helper and/or cytotoxic T lymphocytes provide protection in chimpanzees serially reinfected with the virus. Clearance of the first infection took 3–4 mo and coincided with the delayed onset of CD4 + and CD8 + T cell responses. High frequencies of memory T cells targeting multiple HCV proteins were stable over 7 yr of follow-up. Animals were infected for a second time to assess the protective role of memory T cells. In contrast to the prolonged course of the first infection, viremia was terminated within 14 d. Control of this second infection was kinetically linked to rapid acquisition of virus-specific cytolytic activity by liver resident CD8 + T cells and expansion of memory CD4 + and CD8 + T cells in blood. The importance of memory CD8 + T cells in control of HCV infection was confirmed by antibody-mediated depletion of this lymphocyte subset before a third infection. Virus replication was prolonged despite the presence of memory CD4 + T helper cells primed by the two prior infections and was not terminated until HCV-specific CD8 + T cells recovered in the liver. These experiments demonstrate an essential role for memory CD8 + T cells in long-term protection from chronic hepatitis C.

          Related collections

          Most cited references32

          • Record: found
          • Abstract: found
          • Article: not found

          Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome.

          A random-primed complementary DNA library was constructed from plasma containing the uncharacterized non-A, non-B hepatitis (NANBH) agent and screened with serum from a patient diagnosed with NANBH. A complementary DNA clone was isolated that was shown to encode an antigen associated specifically with NANBH infections. This clone is not derived from host DNA but from an RNA molecule present in NANBH infections that consists of at least 10,000 nucleotides and that is positive-stranded with respect to the encoded NANBH antigen. These data indicate that this clone is derived from the genome of the NANBH agent and are consistent with the agent being similar to the togaviridae or flaviviridae. This molecular approach should be of great value in the isolation and characterization of other unidentified infectious agents.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes.

            Clinical evidence suggests that cellular immunity is involved in controlling human immunodeficiency virus-1 (HIV-1) replication. An animal model of acquired immune deficiency syndrome (AIDS), the simian immunodeficiency virus (SIV)-infected rhesus monkey, was used to show that virus replication is not controlled in monkeys depleted of CD8+ lymphocytes during primary SIV infection. Eliminating CD8+ lymphocytes from monkeys during chronic SIV infection resulted in a rapid and marked increase in viremia that was again suppressed coincident with the reappearance of SIV-specific CD8+ T cells. These results confirm the importance of cell-mediated immunity in controlling HIV-1 infection and support the exploration of vaccination approaches for preventing infection that will elicit these immune responses.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Determinants of Viral Clearance and Persistence during Acute Hepatitis C Virus Infection

              The virological and immunological features of hepatitis C virus (HCV) infection were studied weekly for 6 months after accidental needlestick exposure in five health care workers, four of whom developed acute hepatitis that progressed to chronicity while one subject cleared the virus. In all subjects, viremia was first detectable within 1–2 weeks of inoculation, 1 month or more before the appearance of virus-specific T cells. The subject who cleared the virus experienced a prolonged episode of acute hepatitis that coincided with a CD38+ IFN-γ− CD8+ T cell response to HCV and a small reduction in viremia. Subsequently, a strong CD4+ T cell response emerged and the CD8+ T cells became CD38− and started producing IFN-γ in response to HCV, coinciding with a rapid 100,000-fold decrease in viremia that occurred without a corresponding surge of disease activity. Chronic infection developed in two subjects who failed to produce a significant T cell response and in two other subjects who initially mounted strong CD4+ T cell responses that ultimately waned. In all subjects, viremia was higher at the peak of acute hepatitis than it was when the disease began, and the disease improved during the viremia. These results provide the first insight into the host–virus relationship in humans during the incubation phase of acute HCV infection, and they provide the only insight to date into the virological and immunological characteristics of clinically asymptomatic acute HCV infection, the commonest manifestation of this disease. In addition, the results suggest that the vigor and quality of the antiviral T cell response determines the outcome of acute HCV infection, that the ability of HCV to outpace the T cell response may contribute to its tendency to persist; that the onset of hepatitis coincides with the onset of the CD8+T cell response, that disease pathogenesis and viral clearance are mediated by different CD8+ T cell populations that control HCV by both cytolytic and noncytolytic mechanisms, and that there are different pathways to viral persistence in asymptomatic and symptomatic acute HCV infection.
                Bookmark

                Author and article information

                Journal
                J Exp Med
                The Journal of Experimental Medicine
                The Rockefeller University Press
                0022-1007
                1540-9538
                16 June 2003
                : 197
                : 12
                : 1645-1655
                Affiliations
                [1 ]Center for Vaccines and Immunity, Columbus Children's Research Institute, Columbus, OH 43205
                [2 ]Center for the Study of Hepatitis C, The Rockefeller University, New York, NY 10021
                [3 ]Chiron Corporation, Emeryville, CA 94608
                [4 ]Centocor, Malvern, PA 19355
                [5 ]Division of Viral Pathogenesis, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215
                [6 ]Department of Pediatrics, College of Medicine and Public Health, The Ohio State University, Columbus, OH 43205
                Author notes

                Address correspondence to Christopher M. Walker, Center for Vaccines and Immunity, Columbus Children's Research Institute, 700 Children's Dr., Rm. W503, Columbus, OH 43205. Phone: 614-722-2692; Fax: 614-722-3273; E-mail: walkerc@ 123456pediatrics.ohio-state.edu

                Article
                20030239
                10.1084/jem.20030239
                2193956
                12810686
                e5d96a5b-f1d2-4977-8da1-4afbe64712fb
                Copyright © 2003, The Rockefeller University Press
                History
                : 12 February 2003
                : 8 April 2003
                : 8 April 2003
                Categories
                Article

                Medicine
                immunologic memory,hepatitis c,t lymphocytes,liver diseases,viral hepatitis
                Medicine
                immunologic memory, hepatitis c, t lymphocytes, liver diseases, viral hepatitis

                Comments

                Comment on this article